Responses
Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
491 BASECAMP-1: an observational study to identify relapsed solid tumor patients with human leukocyte antigen (HLA) loss of heterozygosity (LOH) and leukapheresis for future CAR T-cell therapy
Compose a Response to This Article
Other responses
No responses have been published for this article.